Acta Medica Alanya (Oct 2019)

Effects of Tumor Necrosis Factor Alpha Blocker Adalimumab in Experimental Brain Injury

  • Mehmet Yalçın Günal,
  • Seyda Cankaya,
  • Sukru Burak Tonuk,
  • Ekrem Musa Ozdemi̇r,
  • Ayse Arzu Sayın Sakul

DOI
https://doi.org/10.30565/medalanya.632455
Journal volume & issue
Vol. 3, no. 3
pp. 306 – 310

Abstract

Read online

Aim: We aimed to investigate the neuroprotective role of adalimumab based on the hypothesis that "TNF-alpha inhibitor Adalimumab may affect inflammation-related neuronal injury due to its anti-inflammatory effect". Methods: To investigate the effects of Adalimumab, we induced brain injury in mice using a cold trauma model and evaluated the underlying cell survival/ death mechanisms via cresyl violet and calculated infarct/edema volume with image analyze system. Results: Although our data indicated a tendency to decreased infarct and edema volume, these findings are not significant statistically. Conclusion: To the best of our knowledge, this is the first study evaluating the neuroprotective effect of Adalimumab on injured neurons.

Keywords